Published in J Clin Invest on November 01, 1993
Rituximab in the Treatment of Patients With Bullous Pemphigoid | NCT00286325
Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96
Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis. J Exp Med (1997) 1.63
The Src family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment. J Exp Med (2014) 1.59
The role of complement in experimental bullous pemphigoid. J Clin Invest (1995) 1.55
A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest (1997) 1.53
Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid. J Invest Dermatol (2014) 1.47
A recombinant tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress alpha 6 beta 4-mediated cell adhesion to laminins. J Cell Biol (1995) 1.46
Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo. Nat Commun (2016) 1.43
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest (2001) 1.42
Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest (2005) 1.38
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest (2005) 1.36
A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest (2000) 1.30
Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J Clin Invest (2005) 1.25
The pathophysiology of autoimmune blistering diseases. J Clin Invest (2005) 1.10
The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol (2000) 1.10
T cell control in autoimmune bullous skin disorders. J Clin Invest (2006) 1.10
Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med (2007) 1.10
Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest (1996) 1.07
Early neoplastic progression is complement independent. Neoplasia (2005) 1.07
The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol Res (2007) 1.01
Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol (2002) 1.01
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest (1998) 1.00
Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. J Autoimmun (2008) 0.99
Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa. Am J Hum Genet (1997) 0.98
The diagnosis and treatment of autoimmune blistering skin diseases. Dtsch Arztebl Int (2011) 0.94
IgG4 autoantibodies induce dermal-epidermal separation. J Cell Mol Med (2007) 0.94
Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest (2004) 0.93
Autoantibodies against adhesion molecules and structures in blistering skin diseases. J Exp Med (1995) 0.93
Collagen XVII: a shared antigen in neurodermatological interactions? Clin Dev Immunol (2013) 0.92
The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res (1996) 0.92
Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid. J Exp Med (1997) 0.91
Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest (2006) 0.90
Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8. Exp Dermatol (2012) 0.89
Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid. Ann Dermatol (2012) 0.87
Differential roles for beta2 integrins in experimental autoimmune bullous pemphigoid. Blood (2005) 0.87
Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid. J Biol Chem (2011) 0.86
Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma. PLoS One (2010) 0.86
Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen. Am J Pathol (2009) 0.85
Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation. Am J Pathol (2009) 0.85
The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice. PLoS One (2012) 0.85
Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332. Matrix Biol (2010) 0.83
Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid. Matrix Biol (2011) 0.83
The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid. J Biol Chem (2011) 0.82
Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, autoimmunization, and itching in mice. J Invest Dermatol (2014) 0.82
Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes. Clin Exp Immunol (2004) 0.82
Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway. Am J Pathol (2013) 0.82
Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid. Arch Dermatol Res (2007) 0.81
Prevalence of pemphigus and pemphigoid autoantibodies in the general population. Orphanet J Rare Dis (2015) 0.80
Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis (2011) 0.80
Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay. J Am Acad Dermatol (2012) 0.79
Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice. J Invest Dermatol (2007) 0.78
Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases. Clin Diagn Lab Immunol (2004) 0.77
Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice. Orphanet J Rare Dis (2013) 0.77
IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid. J Autoimmun (2016) 0.77
Therapy of autoimmune bullous diseases. Ther Clin Risk Manag (2007) 0.77
14-3-3 sigma isoform interacts with the cytoplasmic domain of the transmembrane BP180 in keratinocytes. J Cell Physiol (2007) 0.76
Multiple mucosal involvement in cicatricial pemphigoid. Acta Otorhinolaryngol Ital (2009) 0.76
Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180. Hybridoma (Larchmt) (2012) 0.75
Basement membranes and autoimmune diseases. Matrix Biol (2016) 0.75
Granulocyte-dependent autoantibody-induced skin blistering. J Vis Exp (2012) 0.75
Itch, eosinophils, and autoimmunity: a novel murine model of bullous pemphigoid. J Invest Dermatol (2015) 0.75
The association of bullous pemphigoid and ulcerative colitis. Dig Dis Sci (2005) 0.75
Pathogenicity of autoantibodies in anti-p200 pemphigoid. PLoS One (2012) 0.75
T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid. Clin Exp Immunol (2015) 0.75
From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases. J Invest Dermatol (2014) 0.75
Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm. Med Mol Morphol (2015) 0.75
Eosinophils in Autoimmune Diseases. Front Immunol (2017) 0.75
The role of hemidesmosomes and focal contacts in the skin visualized by dual-color live cell imaging. Med Mol Morphol (2014) 0.75
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Pemphigus. Medicine (Baltimore) (1953) 2.78
Basement zone antibodies in bullous pemphigoid. JAMA (1967) 2.66
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol (1986) 2.30
Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol (1992) 1.99
Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid. J Clin Invest (1973) 1.73
A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol (1985) 1.67
Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest (1990) 1.67
Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest (1988) 1.65
Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol (1985) 1.60
Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol (1992) 1.44
Herpes gestationis: studies on the binding characteristics, activity and pathogenetic significance of the complement-fixing factor. Clin Exp Immunol (1978) 1.42
HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. J Biochem (1993) 1.40
Herpes gestationis. Immunopathology and characterization of the HG factor. J Clin Invest (1976) 1.34
The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor". J Clin Invest (1976) 1.33
Herpes gestationis: clinical and histologic features of twenty-eight cases. J Am Acad Dermatol (1983) 1.26
Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA. J Invest Dermatol (1990) 1.24
Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest (1991) 1.21
Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest (1988) 1.14
Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid--a preliminary report. J Invest Dermatol (1975) 1.05
Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement, and migrating cells. J Invest Dermatol (1984) 1.04
Immunopathologic study of herpes gestationis in mother and infant. Arch Dermatol (1977) 1.02
The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody. J Invest Dermatol (1989) 0.94
Failure to transfer bullous pemphigoid with serum from patients. Proc Soc Exp Biol Med (1971) 0.93
Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J Clin Invest (1981) 0.92
Plasma exchange in herpes gestationis. Br Med J (1980) 0.88
cDNA analysis predicts a cornea-specific collagen. Proc Natl Acad Sci U S A (1991) 0.88
Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies. J Invest Dermatol (1988) 0.87
Animal models for bullous pemphigoid. Clin Dermatol (1987) 0.86
Herpes gestations with identical lesions in the newborn. Passive transfer of the disease? Arch Dermatol (1976) 0.85
Purification of bullous pemphigoid IgG subclasses and their capability for complement fixation. Acta Derm Venereol (1992) 0.84
Herpes gestationis: ultrastructural identification of the extracellular antigenic sites in diseased skin using immunogold techniques. Br J Dermatol (1991) 0.82
Large-scale forest girdling shows that current photosynthesis drives soil respiration. Nature (2001) 5.95
recD: the gene for an essential third subunit of exonuclease V. Proc Natl Acad Sci U S A (1986) 5.59
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Chi-dependent DNA strand cleavage by RecBC enzyme. Cell (1985) 2.70
RecBC enzyme nicking at Chi sites during DNA unwinding: location and orientation-dependence of the cutting. Cell (1985) 2.66
Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest (1973) 2.55
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Calcifying disorders of the skin. J Am Acad Dermatol (1995) 2.42
Escherichia coli RecBC pseudorevertants lacking chi recombinational hotspot activity. J Bacteriol (1983) 2.37
Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int (1981) 2.36
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol (1986) 2.30
The dynamics of glomerular ultrafiltration in the rat. J Clin Invest (1971) 2.27
Dynamics of glomerular ultrafiltration in the rat. II. Plasma-flow dependence of GFR. Am J Physiol (1972) 2.24
Role of exonuclease III in the base excision repair of uracil-containing DNA. J Bacteriol (1982) 2.23
Pemphigus: is there another half of the story? J Invest Dermatol (2001) 2.22
Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol (1992) 1.99
Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96
Substrate specificity of the DNA unwinding activity of the RecBC enzyme of Escherichia coli. J Mol Biol (1985) 1.91
Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem (1978) 1.89
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med (1989) 1.88
Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics (2001) 1.86
Complete bundle branch block as an independent predictor of all-cause mortality: report of 7,073 patients referred for nuclear exercise testing. Am J Med (2001) 1.84
Roles of RecBC enzyme and chi sites in homologous recombination. Cold Spring Harb Symp Quant Biol (1984) 1.76
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis (1997) 1.75
Isolation of a Bacterial Culture That Degrades Methyl t-Butyl Ether. Appl Environ Microbiol (1994) 1.70
A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol (1985) 1.67
Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest (1990) 1.67
Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran. Biophys J (1975) 1.64
Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol (1972) 1.63
Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest (1983) 1.60
The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med (2000) 1.58
Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol (1997) 1.56
Relative efficiency of chlamydia screening in non-clinical settings in two California counties. Int J STD AIDS (2010) 1.56
The role of complement in experimental bullous pemphigoid. J Clin Invest (1995) 1.55
A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest (1997) 1.53
Unusual alleles of recB and recC stimulate excision of inverted repeat transposons Tn10 and Tn5. Proc Natl Acad Sci U S A (1984) 1.53
Progressive osseous heteroplasia. Arch Dermatol (1996) 1.51
The transfection of epidermal keratin genes into fibroblasts and simple epithelial cells: evidence for inducing a type I keratin by a type II gene. Cell (1987) 1.47
Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules. J Clin Invest (1977) 1.46
Immunological comparison of desmosomal components from several bovine tissues. J Cell Biochem (1984) 1.46
Behçet's disease. Int J Dermatol (1984) 1.45
Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol (1993) 1.44
D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease. J Am Acad Dermatol (1997) 1.43
The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol (2003) 1.43
Determination of glomerular size-selectivity in the normal rat with Ficoll. J Am Soc Nephrol (1992) 1.42
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest (2001) 1.42
Quantitative assessment of proximal tubule function in single nephrons of the rat kidney. Am J Physiol (1971) 1.41
Postglomerular vascular protein concentration: evidence for a causal role in governing fluid reabsorption and glomerulotublar balance by the renal proximal tubule. J Clin Invest (1971) 1.41
Endothelium-dependent vascular responses. Mediators and mechanisms. J Clin Invest (1989) 1.36
The RecD subunit of the Escherichia coli RecBCD enzyme inhibits RecA loading, homologous recombination, and DNA repair. Proc Natl Acad Sci U S A (2000) 1.35
The human keratin genes and their differential expression. Curr Top Dev Biol (1987) 1.34
Pemphigoid and pemphigus antigens in cultured epidermal cells. Br J Dermatol (1978) 1.32
Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol (1998) 1.31
On the molecular organization, diversity and functions of desmosomal proteins. Ciba Found Symp (1987) 1.31
A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest (2000) 1.30
The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol (1999) 1.30
Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall. J Gen Physiol (1979) 1.30
Sebaceoma. A distinctive benign neoplasm of adnexal epithelium differentiating toward sebaceous cells. Am J Dermatopathol (1984) 1.28
Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate. J Clin Invest (1976) 1.27
Natural (13)C abundance reveals trophic status of fungi and host-origin of carbon in mycorrhizal fungi in mixed forests. Proc Natl Acad Sci U S A (1999) 1.26
Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol (1997) 1.26
Pressures in cortical structures of the rat kidney. Am J Physiol (1972) 1.25
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatry (2005) 1.22
Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest (1991) 1.21
Pathophysiology of altered glomerular function in aminoglycoside-treated rats. Kidney Int (1981) 1.20
Cloning of the dut (deoxyuridine triphosphatase) gene of Escherichia coli. Gene (1980) 1.20
Isolation of pemphigus antigen from human saliva. J Immunol (1980) 1.20
Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia. Leukemia (2011) 1.18
Activator-mediated disruption of sequence-specific DNA contacts by the general transcription factor TFIIB. Genes Dev (2001) 1.18
Isolation of the non-glycosylated proteins of desmosomes and immunolocalization of a third plaque protein: desmoplakin III. Proc Natl Acad Sci U S A (1985) 1.17
Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest (1990) 1.16
Mechanism of reduced glomerular filtration rate in chronic malnutrition. J Clin Invest (1980) 1.16
Permselectivity of of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using neutral dextran. J Clin Invest (1976) 1.15
Increased calmodulin levels in psoriasis and low Ca++ regulated mouse epidermal keratinocyte cultures. J Invest Dermatol (1985) 1.15
Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest (1988) 1.14
On the mechanism of inhibition in fluid reabsorption by the renal proximal tubule of the volume-expanded rat. J Clin Invest (1971) 1.14
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest (1997) 1.13
Diversity and abundance of resupinate thelephoroid fungi as ectomycorrhizal symbionts in Swedish boreal forests. Mol Ecol (2000) 1.12
Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest (2000) 1.12